# Myeloproliferative Neoplasms (MPN) and COVID-19

> **NCT04385160** · — · COMPLETED · sponsor: **FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS** · enrollment: 552 (actual)

## Conditions studied

- Myeloproliferative Neoplasm
- COVID

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04385160
- **Lead sponsor:** FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-13
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-08-31
- **Target enrollment:** 552 (ACTUAL)
- **Last updated:** 2025-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04385160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04385160, "Myeloproliferative Neoplasms (MPN) and COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04385160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*